This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Newsletter Archive
Men's Health Weekly
Uroalerts Men's Health Weekly
August 11, 2025
Videos
Peer-to-Peer Clinical Conversations
Overview of Surgical Treatments for Male Stress Urinary Incontinence - Craig Comiter
Craig Comiter
Alan Wein interviews Craig Comiter about post-prostatectomy incontinence management.
View
Early Palliative Care Boosts Quality of Life for Prostate Cancer Patients - Michael Rabow
Michael Rabow
Michael Rabow joins Ruchika Talwar to discuss the benefits of early palliative care intervention in prostate cancer patients.
View
Beyond the Abstracts
Can Preoperative Transurethral Catherization Reduce the Risk of Urethral Stricture after Endoscopic Treatment of the Prostate? - Beyond the Abstract
Querying the Capability of the Post-HoLEP Endoscopic Aspect of the Membranous Urethral Mucosa in Predicting Urinary Incontinence: A Prospective AI-Based Analysis - Beyond the Abstract
Conference Coverage
AUA 2025: Second Opinion Cases: Penile Fracture
Articles
Editor Selected Abstracts and Commentaries
Male Infertility
Urgent need for inclusion of male infertility in global health strategies: insights from the GBD 2021 Study.
Proteomics of Oligoasthenoteratozoospermia: Progress in research.
Rescue of male infertility by human PRSS55 in transgenic mice establishes a contraceptive research model.
Iron biomarkers in men with infertility are associated with sperm DNA hydroxymethylation and cumulative live birth rates: a prospective study.
Sensorineural deafness and male infertility: a contiguous gene deletion syndrome.
Insights from a Pseudo-Polygyny Cohort unmasking high sperm concentration and low forward motility as potential risk factors for recurrent failure of sperm donation IVF (RFDI), a subset of unexplained male infertility (UMI).
Erectile Dysfunction
The relationship between erectile dysfunction and obstructive sleep apnoea and the impact on severity of ED following treatment of OSA: A systematic review.
Genetic and epigenetic landscape of erectile dysfunction: a comprehensive review.
BPH - Benign Prostatic Enlargement
Risk factors for depression in middle-aged and elderly males with benign prostatic hyperplasia/lower urinary tract symptoms.
Comparative Analysis of 30- and 90-Day Outcomes of Aquablation vs Other Surgical Treatments for Benign Prostatic Hyperplasia.
Beyond the Prostate: A Visionary Study on Ocular Impacts of Benign Prostatic Hyperplasia Drugs.
Comparison of Serenoa repens, lycopene, and selenium versus dutasteride for the treatment of LUTS/BPH: an Italian multicenter case-control prospective study (COMP study).
Penile & Urethral Cancers
A rare case of penile metastasis from renal cell carcinoma following combination therapy with immune checkpoint and tyrosine-kinase inhibitors: A case report and literature review.
The prognostic role of HPV status in penile squamous cell carcinoma: a systematic review and meta-analysis.
Current practices and variability in dynamic sentinel node biopsy for penile cancer: A survey of European Referral Centers.
Penile carcinoma: the importance of histological classification and new treatment strategies.
Testicular Cancer
Expression of the novel serum biomarker of testicular germ cell tumours miR-371a-3p in serum of pregnant women: a case-control study.
Prostate Cancer
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial.
Elevating the Patient Voice: Understanding Treatment Preferences in Patients with Advanced Prostate Cancer - Beyond the Abstract
Androgen deprivation-mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion.
Knowledge and attitudes toward prostate cancer germline genetic testing among Hispanic males.
Activity of Platinum Monotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer and DNA Damage Repair Gene Alterations.
Automated Extraction of Imaging and Pathology Data From Diverse Prostate Cancer Electronic Records.
Long-term Cancer Control Outcomes After Robot-assisted Radical Prostatectomy in Pathologically Non-organ-confined High-risk Prostate Cancer: 20-year Report from a Single Tertiary Referral Center.
Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer.
Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity.
Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence.
Prostate Imaging for Recurrence Reporting: User Guide.
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial.
Evaluating a Prostate Cancer Education and Navigation to Screening Program for Black Men in South Carolina, U.S.
Diagnostic accuracy of abbreviated biparametric MRI for prostate cancer screening: a prospective feasibility study (ReIMAGINE study).
Treatment choice and sexual health outcomes in gay and bisexual men with prostate cancer.
Surgical Wait Time Is Not Associated With Oncological or Psychosocial Outcomes After Robotic Radical Prostatectomy.
Proteomic profiling of extracellular vesicles distinguishes prostate cancer molecular subtypes.
Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate Cancer.
External Validation of the International Staging Collaboration for Cancer of the Prostate (STAR-CAP) Prognostic System in Patients Managed with Active Surveillance.
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
Oncological safety of testosterone replacement therapy in men with localised prostate cancer: a systematic review of observational studies.
Prostate cancer germline variants with therapeutic implications.
Assessing the uptake of core outcome sets in randomized controlled trials for localized prostate cancer: A cross-sectional study.
Role of the Stockholm3 Test in Guiding Confirmation Biopsy Decisions for Patients with Prostate Cancer on Active Surveillance.
Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study.
Utilization of Incontinence Procedures Following Prostate Cancer Treatment: A Population-Level Analysis.
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.
Dosimetric Clues to Addressing Urinary Toxicity Following Stereotactic Prostate Radiation Therapy.
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomy.
Prostate Specific Antigen Testing and Prostate Cancer Diagnosis Rates Among Transgender and Nonbinary Patients: Retrospective Review of a Single-Institution Experience.
Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer.
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial.
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience - Beyond the Abstract
Tailored Use of PSA Density According to Multiparametric MRI Index Lesion Location: Results of a Large, Multi-Institutional Series - Beyond the Abstract
Germline Testing for Prostate Cancer: Current State and Opportunities for Enhanced Access - Beyond the Abstract
CONNECT WITH US
Questions or Comments? Email us at
editors@urotoday.com
Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523
You are receiving this email because you have chosen to receive emails from UroToday.
Add us to your address book
View this email as a web page
Forward to a colleague
Manage your subscriptions
Unsubscribe
Copyright ©2025 Digital Science Press, LLC
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free